Loss-Of-Function Of Pbrm1 To Predict Response To Anti-Pd-1/Pd-L1 Therapy In Metastatic Renal Cell Carcinoma.
Diana Miao,Claire Margolis,Dylan J. Martini,Stephanie A. Mullane,Dana Cullen,Christine Horak,Megan Wind-Rotolo,Matthew D. Hellmann,Martin H. Voss,Robert J. Motzer,Craig Norton,Sabina Signoretti,Alexandra Snyder Charen,Eliezer M. Van Allen,Toni K. Choueiri JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
